Novo Nordisk (NVO) Stock Rebrands to “Novo” as It Fights for Obesity Market Share
TLDR
- Novo Nordisk is rebranding to “Novo” with a new tagline: “Lasting Health Starts Now”
- NVO stock is down about 15% this year despite strong oral Wegovy sales
- The company holds 38.8% obesity market share vs. Eli Lilly’s 60.9% in Q2
- A new cultural framework called “The Novo Way” outlines four operating principles
- Full business strategy details will be revealed at Capital Markets Day on September 21 in London
Novo Nordisk is turning the page. The Danish drugmaker announced Monday it is rebranding to “Novo” and overhauling its corporate culture as it works to claw back market share in the obesity drug space.
NVO stock was trading down 2.14% at the time of writing, and is down roughly 15% year-to-date, even as the oral version of Wegovy surpassed 3 million prescriptions as of June.
The rebrand centres on the phrase “Lasting Health Starts Now,” a push to make the company more relevant to everyday patients and build trust with the public.
“Novo Nordisk A/S” stays as the legal name globally. The “Novo” shorthand will be used day-to-day, alongside an updated visual identity that keeps the Apis bull logo from the company’s heritage.
… Continue reading the full article at the original source below.
